Communications of the ACM
ACM Careers
Promising Gene Therapies Pose Million-Dollar Conundrum
People with sickle cell anaemia are among those targeted by a slew of new gene therapies.
Credit: Kim Hairston/Baltimore Sun/MCT/Getty
Drugs that act by modifying a patient’s genes are close to approval in the United States, and one is already available in Europe. The developments mark a triumph for the field of gene therapy, once considered controversial.
From Nature
View Full Article
No entries found